These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 16911930

  • 1. Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B.
    Xu XW, Chen YG.
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):350-9. PubMed ID: 16911930
    [Abstract] [Full Text] [Related]

  • 2. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
    Buster EH, van Erpecum KJ, Schalm SW, Zaaijer HL, Brouwer JT, Gelderblom HC, de Knegt RJ, Minke Bakker C, Reesink HW, Janssen HL, Netherlands Association of Gastroenterologists and Hepatologists.
    Neth J Med; 2008 Aug; 66(7):292-306. PubMed ID: 18663260
    [Abstract] [Full Text] [Related]

  • 3. A review of entecavir in the treatment of chronic hepatitis B infection.
    Rivkin A.
    Curr Med Res Opin; 2005 Nov; 21(11):1845-56. PubMed ID: 16307706
    [Abstract] [Full Text] [Related]

  • 4. Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.
    Sims KA, Woodland AM.
    Pharmacotherapy; 2006 Dec; 26(12):1745-57. PubMed ID: 17125436
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of HBeAg-positive patients with nucleos/tide analogues.
    Coffin CS, Lee SS.
    Liver Int; 2009 Jan; 29 Suppl 1():116-24. PubMed ID: 19207974
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of chronic hepatitis B].
    Marcellin P, Asselah T, Boyer N.
    Rev Prat; 2005 Mar 31; 55(6):624-32. PubMed ID: 15913114
    [Abstract] [Full Text] [Related]

  • 9. Treatment of chronic hepatitis B: case selection and duration of therapy.
    Leung N.
    J Gastroenterol Hepatol; 2002 Apr 31; 17(4):409-14. PubMed ID: 11982721
    [Abstract] [Full Text] [Related]

  • 10. Therapy of chronic hepatitis B: trends and developments.
    Delaney WE, Borroto-Esoda K.
    Curr Opin Pharmacol; 2008 Oct 31; 8(5):532-40. PubMed ID: 18835366
    [Abstract] [Full Text] [Related]

  • 11. Management of chronic hepatitis B virus infection: a new era of disease control.
    Farrell GC, Teoh NC.
    Intern Med J; 2006 Feb 31; 36(2):100-13. PubMed ID: 16472264
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacology, clinical efficacy and safety of lamivudine in hepatitis B virus infection.
    Kumar M, Sarin SK.
    Expert Rev Gastroenterol Hepatol; 2008 Aug 31; 2(4):465-95. PubMed ID: 19072396
    [Abstract] [Full Text] [Related]

  • 14. Entecavir for the treatment of chronic hepatitis B virus infection.
    Matthews SJ.
    Clin Ther; 2006 Feb 31; 28(2):184-203. PubMed ID: 16678641
    [Abstract] [Full Text] [Related]

  • 15. Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.
    Gish RG, Lok AS, Chang TT, de Man RA, Gadano A, Sollano J, Han KH, Chao YC, Lee SD, Harris M, Yang J, Colonno R, Brett-Smith H.
    Gastroenterology; 2007 Nov 31; 133(5):1437-44. PubMed ID: 17983800
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Entecavir for chronic hepatitis B: a review.
    Palumbo E.
    Ther Drug Monit; 2008 Feb 31; 30(1):1-4. PubMed ID: 18223455
    [Abstract] [Full Text] [Related]

  • 20. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment.
    Liaw YF.
    Liver Int; 2009 Jan 31; 29 Suppl 1():100-7. PubMed ID: 19207972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.